Biomarin Pharmaceutical (BMRN) Q4 2017 Earnings

26OctConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-0.53
-0.38
-0.22
-0.07

Details

Expected EPS
-0.19
Actual EPS
-0.07
Surprise EPS
0.12
Surprise Percent
+63.16%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.07 per share for Q4 2017.

0 Comments

Share your thoughts